Journal of Molecular Biology
Role of effector binding in allosteric control of ribonucleoside diphosphate reductase☆
References (20)
Analyt. Biochem
(1960)- et al.
J. Biol. Chem
(1967) - et al.
J. Mol. Biol
(1969) - et al.
J. Biol. Chem
(1969) - et al.
Biochim. biophys. Acta
(1962) - et al.
Biochim. biophys. Acta
(1953) - et al.
J. Biol. Chem
(1966) - et al.
J. Biol. Chem
(1966) - et al.
J. Mol. Biol
(1963) - et al.
J. Mol. Biol
(1965)
Cited by (184)
Structural insights into the half-of-sites reactivity in homodimeric and homotetrameric metalloenzymes
2023, Current Opinion in Chemical BiologyCYP24A1: structure, function, and physiological role
2023, Feldman and Pike's Vitamin D: Volume One: Biochemistry, Physiology and DiagnosticsStructure-based in silico investigation of antagonists of human ribonucleotide reductase from Annona muricata
2023, Informatics in Medicine UnlockedStarting a new chapter on class Ia ribonucleotide reductases
2022, Current Opinion in Structural BiologyCitation Excerpt :The identity of the substrate reduced in the active site (ADP, CDP, GDP, or UDP) is allosterically regulated by the identity of the deoxyribonucleotide (dATP, dGTP, or TTP) that is bound in the nearby allosteric specificity site at the α2 dimer interface (Figure 1b) [12–14]. Overall enzyme activity is allosterically regulated via a third nucleotide binding site at the N-terminus of α2 and the cellular ratio of ATP to dATP (Figure 1b) [13,14]. Although all characterized class Ia RNRs are subject to allosteric activity regulation by ATP and dATP, the molecular mechanisms are not always the same.
A ribonucleotide reductase from clostridium botulinum reveals distinct evolutionary pathways to regulation via the overall activity site
2020, Journal of Biological Chemistry
- ☆
This work was supported by grants to one of us (P. R.) from the Swedish Medical Research Council, the Swedish Cancer Society, the Damon Runyon Memorial Fund (DRG470 I) and by a personal grant to the other author (N. C. B.) from the Swedish Cancer Society.